Clincosm LogoSign in Get a demo

inflammatory gastrointestinal disease

Showing 1 - 1 of 1
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Granulomatous Disease, Inflammatory Gastrointestinal Disease, Inflammatory Skin Disease Trial run by the NIAID (XELJANZ

Enrolling by invitation
  • Chronic Granulomatous Disease
  • +3 more
  • XELJANZ (tofacitinib)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023